Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug
|
| gptkbp:availableFormats |
tablet
liquid injection nasal spray |
| gptkbp:brand |
Neo-Synephrine
Sudafed PE Little Noses |
| gptkbp:chemicalFormula |
C9H13NO2
|
| gptkbp:clinicalTrials |
Phase IV
|
| gptkbp:composedOf |
reduction of 4-hydroxyphenylacetone
|
| gptkbp:contraindication |
gptkb:MAO_inhibitors
severe hypertension ventricular_tachycardia |
| gptkbp:dissolved |
soluble in water
soluble in alcohol |
| gptkbp:drugInterdiction |
peak plasma concentration in 1-2 hours
half-life of 2-3 hours |
| gptkbp:duration |
4 hours
|
| gptkbp:gestationPeriod |
C
|
| https://www.w3.org/2000/01/rdf-schema#label |
phenylephrine
|
| gptkbp:inheritsFrom |
30 minutes
|
| gptkbp:interactsWith |
beta-blockers
digoxin tricyclic antidepressants |
| gptkbp:isATypeOf |
61-76-7
|
| gptkbp:lastProduced |
1930s
|
| gptkbp:notableFeature |
Tylenol Sinus
Allegra-D Benadryl_Allergy_Plus_Sinus |
| gptkbp:nutritionalValue |
liver
|
| gptkbp:operates_in |
R01BA03
|
| gptkbp:patentType |
yes
|
| gptkbp:publisher |
6320
|
| gptkbp:relatedPatent |
ephedrine
pseudoephedrine |
| gptkbp:route |
oral
intravenous intranasal |
| gptkbp:sideEffect |
dizziness
headache nausea hypertension reflex bradycardia |
| gptkbp:triggerType |
alpha-1 adrenergic receptor agonist
|
| gptkbp:usedFor |
nasal congestion
allergic rhinitis hypotension |
| gptkbp:waterManagement |
urine
|
| gptkbp:weight |
167.21 g/mol
|